THU-240 30% of inactive HBsAg carriers achieved clinical cure at 48 weeks with Pegylated Interferon alpha-2b therapy: a multicenter real- world study (STARHB Project in China)- 2.5 years data updateShan Ren, Xinyue Chen, Sujun Zheng et al.|Journal of Hepatology|2025Cited by 0